heat shock protein family A (Hsp70) member 8 pseudogene 20Genealiases: []
Q-omics provides the consensus-scored HSPA8P20 profile across patient tissues and cancer cell-line models. HSPA8P20 expression is associated with patient survival in 14 of 34 cancer types, with the highest sampling consensus in LIHC. Among the 18 cancer types available for tumor–normal comparison, HSPA8P20 is differentially expressed in 1, with the highest sampling consensus in COAD. Additionally, HSPA8P20 RNA expression shows 6,832 significant gene co-expression associations, with the highest sampling consensus in THYM. Together, these results highlight LIHC, COAD, and THYM as cancer lineages where HSPA8P20 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for HSPA8P20 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes HSPA8P20 survival associations across molecular data types. HSPA8P20 RNA expression shows survival associations in the most cancer types (14). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible HSPA8P20 RNA expression–survival associations across cancer types. High HSPA8P20 expression shows unfavorable associations in LIHC, MESO, KICH and COAD, but favorable associations in UCS and LAML. The LIHC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .006). Together, the overview and detailed table identify LIHC as the clearest survival context for HSPA8P20 RNA expression.
This table summarizes HSPA8P20 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 1. The strongest signals are observed in COAD for RNA.
This table ranks reproducible tumor–normal expression differences for HSPA8P20. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. HSPA8P20 shows higher tumor expression in COAD. The COAD box plot shows higher HSPA8P20 RNA expression in tumor versus normal tissue (log2 FC = +0.049, t-test p = .013).
This table shows molecular features associated with HSPA8P20 in patient tissues and cancer cell lines. In patient samples, HSPA8P20 shows the broadest associations at the RNA and protein expression levels, with THYM recurring as the lineage with the largest associated feature set.
